Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 551

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 551
---
 |     27,106 |     |   |    * |   |
| James Manuso(6)                                 |     |              |     27,106 |     |   |    * |   |
| Robert E. Hoffman(7)                            |     |              |      5,354 |     |   |    * |   |
| Craig Tendler, M.D.(8)                          |     |              |          — |     |   |      |   |
| All Officers and Directors as a group (7 Total) |     |              |  3,210,472 |     |   |  7.4 | % |
| Greater than 5% Stockholders                    |     |              |            |     |   |      |   |
| Vijay Patel(9)                                  |     |              | 12,364,430 |     |   | 25.7 | % |
| CA Patel F&F Investments, LLC (10)              |     |              |  2,572,582 |     |   |  5.8 | % |
| KP Biotech Group, LLC(11)                       |     |              |  2,572,582 |     |   |  5.8 | % |
| Samir Patel(12)                                 |     |              |  2,466,377 |     |   |  5.7 | % |
| Charles Theofilos, M.D. (13)                    |     |              |  2,506,321 |     |   |  5.7 | % |

| * | Represents beneficial ownership of less than 1%. |

| (1) | Except as otherwise indicated, the address of each beneficial owner is c/o TuHURA Biosciences, Inc., 10500 University Center Dr., Suite 110, Tampa, FL 33612. |

342

| (2) | Consists of (i) 2,323,307 shares of TuHURA Common Stock and (ii) 469,268 options to purchase TuHURA Common Stock held directly by Dr. Bianco exercisable within 60 days after March 31, 2025. |

| (3) | Consists of 295,440 options to purchase TuHURA Common Stock held directly by Mr. Dearborn exercisable within 60 days after March 31, 2025. |

| (4) | Cons